๐ŸŽ Black Friday: up to 50% off of annual plans
GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
15.45
-1.05 (-6.36%)
Nov 20, 2026, 1:30 PM CST

TPE:3164 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
396.64401.23385.37318.02368.55427.93
Revenue Growth
1.32%4.11%21.18%-13.71%-13.88%31.59%
Gross Profit
234.32251.63238.18211.19256.72299.33
Operating Income
38.5357.7540.636.9961.97125.04
Net Income
62.0157.257.2532.9956.98113.13
Earnings Per Share
0.710.660.660.380.661.30
EPS Growth
81.62%0%73.68%-42.40%-49.25%88.41%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Genmont (China)
46.6940.218.57--
Genmont Biotech Inc.
354.54345.16309.45368.55427.93
Total
401.23385.37318.02368.55427.93

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
371.8365.36358.64328.3400.94421.73
Total Debt
132.32110.31118.6158.3134.5532.73
Net Cash (Debt)
239.48255.05240.03270366.4389
Net Cash Growth
12.75%6.26%-11.10%-26.31%-5.81%-9.70%
Net Cash Per Share
2.752.952.773.124.234.48

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
118.773.6123.9534.6136.98111.66
Capital Expenditures
-0.57-3.41-44.05-33.31-71.19-116.94
Free Cash Flow
118.1370.1979.891.2965.79-5.28
Free Cash Flow Growth
32.01%-12.14%6088.38%-98.04%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
59.08%62.72%61.80%66.41%69.66%69.95%
Operating Margin
9.71%14.39%10.54%2.20%16.81%29.22%
Pretax Margin
19.26%15.87%16.79%8.86%17.98%32.58%
Profit Margin
15.63%14.26%14.86%10.37%15.46%26.44%
FCF Margin
29.78%17.49%20.73%0.41%17.85%-1.23%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.8000.8000.8000.5000.7001.100
Dividend Per Share Growth
0%0%60.00%-28.57%-36.36%57.14%
Dividend Yield
5.18%4.36%3.96%2.02%2.95%4.52%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
21.7627.5930.5264.7735.9318.59
P/FCF Ratio
11.2522.4921.871655.1831.11-
PS Ratio
3.353.934.546.725.554.92